Medigen Vaccine Biologics Strategic Asset Allocation Index
Medigen Vaccine Biologics strategic asset allocation index. Medigen Vaccine Biologics (6547) has a Strategic Asset Allocation Index of 31.8% as of June 2023. Strategic assets (PP&E of NT$1.43 Billion plus long-term investments of NT$-) total NT$1.43 Billion, measured against net assets of NT$4.50 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Medigen Vaccine Biologics to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Medigen Vaccine Biologics (2017–2022)
Strategic asset allocation index of Medigen Vaccine Biologics from 2017 to 2022. This chart shows how Medigen Vaccine Biologics's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 31.8%, representing strategic assets of NT$1.43 Billion against net assets of NT$4.50 Billion TWD. Check how tangible is Medigen Vaccine Biologics's equity to evaluate the tangible quality of the company's equity base.
Medigen Vaccine Biologics Strategic Asset Allocation Index by Year (2017–2022)
Medigen Vaccine Biologics strategic asset allocation index by year from 2017 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Medigen Vaccine Biologics from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Medigen Vaccine Biologics market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 29.2% | NT$1.47 Billion | NT$1.47 Billion | NT$- | NT$5.03 Billion | ▼ -1.0 pp |
| 2021 | 30.2% | NT$1.41 Billion | NT$1.41 Billion | NT$- | NT$4.68 Billion | ▼ -12.5 pp |
| 2020 | 42.8% | NT$1.34 Billion | NT$1.34 Billion | NT$- | NT$3.14 Billion | ▼ -78.9 pp |
| 2019 | 121.7% | NT$1.66 Billion | NT$1.66 Billion | NT$- | NT$1.37 Billion | ▲ +39.7 pp |
| 2018 | 82.0% | NT$1.32 Billion | NT$1.32 Billion | NT$- | NT$1.61 Billion | ▼ -9.5 pp |
| 2017 | 91.5% | NT$1.39 Billion | NT$1.39 Billion | NT$- | NT$1.52 Billion | — |